Principal Securities’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56M Buy
81,221
+5,203
+7% +$164K 0.04% 412
2025
Q4
$2.24M Buy
76,018
+28,150
+59% +$782K 0.03% 431
2025
Q3
$1.21M Buy
47,868
+269
+0.6% +$6.56K 0.02% 610
2025
Q2
$1.14M Buy
47,599
+12,000
+34% +$278K 0.02% 571
2025
Q1
$901K Hold
35,599
0.02% 587
2024
Q4
$901K Buy
35,599
+10,376
+41% +$263K 0.02% 586
2024
Q3
$629K Buy
25,223
+5,669
+29% +$168K 0.02% 683
2024
Q2
$580K Buy
19,554
+12,537
+179% +$348K 0.02% 652
2024
Q1
$212K Buy
7,017
+5,380
+329% +$149K 0.01% 989
2023
Q4
$46.8K Buy
+1,637
New +$48.1K ﹤0.01% 1517

Other funds holding RTO

Principal Securities's RTO Position: Q1 2026 in Review

Principal Securities increased its Rentokil (RTO) stake by 6.8% in Q1 2026, buying an estimated $164K and bringing the position to 81,221 shares worth $2.56M. The position accounts for 0.04% of the portfolio, ranked #412.

Principal Securities first reported a position in RTO in Q4 2023 and has held it in 10 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Principal Securities held 81,221 shares of Rentokil worth $2.56M as of Q1 2026.
  • Principal Securities bought 5,203 Rentokil shares in Q1 2026, an estimated $164K.
  • Rentokil made up 0.04% of Principal Securities's portfolio in Q1 2026, its #412 holding.
  • Principal Securities first reported a position in Rentokil in Q4 2023 and has held it in 10 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.